Cargando…

Impact of time between faecal immunochemical tests in colorectal cancer screening on screening results: A natural experiment

Repeated rounds of faecal immunochemical testing (FIT) for occult blood is a common method for screening for colorectal cancer (CRC). However, the time interval between FIT rounds is not thoroughly investigated. In a CRC screening trial in South‐Eastern Norway, individuals were invited for biennial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ribe, Sara G., Botteri, Edoardo, Løberg, Magnus, Randel, Kristin R., Kalager, Mette, Nilsen, Jens Aksel, Gulichsen, Elisabeth H., Holme, Øyvind
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Cancer Therapy and Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098820/ https://www.ncbi.nlm.nih.gov/pubmed/36346118 http://dx.doi.org/10.1002/ijc.34351

Ejemplares similares

Characteristics of nonparticipants in a randomised colorectal cancer screening trial comparing sigmoidoscopy and faecal immunochemical testing
por: Botteri, Edoardo, et al.
Publicado: (2022)

The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening
por: Kooyker, Arthur I., et al.
Publicado: (2020)

Lifestyle predictors for non-participation and outcome in the second round of faecal immunochemical test in colorectal cancer screening
por: Knudsen, Markus Dines, et al.
Publicado: (2017)

Factors predicting improved compliance towards colonoscopy in individuals with positive faecal immunochemical test (FIT)
por: Lim, Tian‐Zhi, et al.
Publicado: (2021)

The potential of breast cancer screening in Europe
por: Zielonke, Nadine, et al.
Publicado: (2020)

Use of thermo‐coagulation as an alternative treatment modality in a ‘screen‐and‐treat’ programme of cervical screening in rural Malawi
por: Campbell, Christine, et al.
Publicado: (2016)

Breast Cancer Screening Program in Morocco: Status of implementation, organization and performance
por: Basu, Partha, et al.
Publicado: (2018)

Human papillomavirus self‐sampling with mRNA testing benefits routine screening
por: Auvinen, Eeva, et al.
Publicado: (2022)

Systematic reviews as a ‘lens of evidence’: Determinants of benefits and harms of breast cancer screening
por: Mandrik, Olena, et al.
Publicado: (2019)

Identifying key factors for the effectiveness of pancreatic cancer screening: A model‐based analysis
por: Koopmann, Brechtje D. M., et al.
Publicado: (2021)

Estimation of overdiagnosis in colorectal cancer screening with sigmoidoscopy and faecal occult blood testing: comparison of simulation models
por: Wieszczy, Paulina, et al.
Publicado: (2021)

Finding the optimal mammography screening strategy: A cost‐effectiveness analysis of 920 modelled strategies
por: Kregting, Lindy M., et al.
Publicado: (2022)

Lower participation among immigrants in colorectal cancer screening in Norway
por: Bhargava, Sameer, et al.
Publicado: (2023)

Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women
por: Gultekin, Murat, et al.
Publicado: (2017)

Screen‐detected and interval colorectal cancers in England: Associations with lifestyle and other factors in women in a large UK prospective cohort
por: Blanks, Roger, et al.
Publicado: (2019)

Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology‐screened referral population
por: Leeman, Annemiek, et al.
Publicado: (2018)

Self‐sampling as the principal modality for population based cervical screening: Five‐year follow‐up of the PaVDaG study
por: Stanczuk, Grazyna A., et al.
Publicado: (2021)

Trends in frequency and outcome of high‐risk breast lesions at core needle biopsy in women recalled at biennial screening mammography, a multiinstitutional study
por: Luiten, Jacky D., et al.
Publicado: (2019)

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
por: Gottschlich, Anna, et al.
Publicado: (2022)

Bounding the per-protocol effect in randomized trials: an application to colorectal cancer screening
por: Swanson, Sonja A., et al.
Publicado: (2015)

Effect of screening mammography on breast cancer mortality: Quasi‐experimental evidence from rollout of the Dutch population‐based program with 17‐year follow‐up of a cohort
por: Van Ourti, Tom, et al.
Publicado: (2019)

Cross‐sectional survey of the impact of the COVID‐19 pandemic on cancer screening programs in selected low‐ and middle‐income countries: Study from the IARC COVID‐19 impact study group
por: Villain, Patricia, et al.
Publicado: (2021)

Benefits and harms of mammography screening
por: Løberg, Magnus, et al.
Publicado: (2015)

Special issue “The advance of solid tumor research in China”: Participants with a family history of cancer have a higher participation rate in low‐dose computed tomography for lung cancer screening
por: Guo, Lan‐Wei, et al.
Publicado: (2022)

Interval colorectal cancers after negative faecal immunochemical test in the New Zealand Bowel Screening Pilot
por: Saw, Kai Sheng, et al.
Publicado: (2023)

Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial
por: Nielson, Carrie M., et al.
Publicado: (2018)

Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials
por: Holme, Øyvind, et al.
Publicado: (2017)

Breast cancer survivors' risk of interval cancers and false positive results in organized mammography screening
por: Njor, Sisse Helle, et al.
Publicado: (2020)

Faecal immunochemical test outside colorectal cancer screening?
por: Pin-Vieito, Noel, et al.
Publicado: (2021)

Detection of cancers and advanced adenomas in asymptomatic participants in colorectal cancer screening: a cross-sectional study
por: Schult, Anna Lisa, et al.
Publicado: (2021)

Polypectomy techniques among gastroenterologists in Norway – a nationwide survey
por: Pedersen, Ina B., et al.
Publicado: (2018)

Establishment and validation of a two‐step screening scheme for improved performance of serological screening of nasopharyngeal carcinoma
por: Li, Tingdong, et al.
Publicado: (2018)

Impact on immigrant screening adherence with introduction of a population‐based colon screening program in Ontario, Canada
por: Moustaqim‐Barrette, Amina, et al.
Publicado: (2019)

At what age should the Uyghur minority initiate cervical cancer screening if screened using careHPV
por: Abulizi, Guzhalinuer, et al.
Publicado: (2021)

Screening mammography: sparing the emperor's blushes
por: Niraula, Saroj
Publicado: (2016)

Implementation of p16/Ki67 dual stain cytology in a Danish routine screening laboratory: Importance of adequate training and experience
por: Hammer, Anne, et al.
Publicado: (2020)

Cervical cancer screening in a low‐resource setting: a pilot study on an HPV‐based screen‐and‐treat approach
por: Kunckler, Margot, et al.
Publicado: (2017)

Impact of screening and follow‐up colonoscopy adenoma sensitivity on colorectal cancer screening outcomes in the CRC‐AIM microsimulation model
por: Fisher, Deborah A., et al.
Publicado: (2020)

Breast cancer risk stratification for mammographic screening: A nation‐wide screening cohort of 24,431 women in Singapore
por: Ho, Peh Joo, et al.
Publicado: (2021)

Lifestyle predictors for inconsistent participation to fecal based colorectal cancer screening
por: Knudsen, Markus Dines, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_00g76dpg7hm11vcvo79jmcc9or